5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.02▲ | 2.02▲ | 2.03▲ | 2.07▼ | 2.12▼ |
MA10 | 2.02▲ | 2.02▲ | 2.01▲ | 2.19▼ | 2.56▼ |
MA20 | 2.01▲ | 2.04▲ | 2.07▼ | 2.10▼ | 5.29▼ |
MA50 | 2.09▼ | 2.16▼ | 2.22▼ | 2.85▼ | 37.58▼ |
MA100 | 2.24▼ | 2.23▼ | 2.14▼ | 5.88▼ | 77.77▼ |
MA200 | 2.22▼ | 2.08▼ | 2.21▼ | 24.39▼ | 184.76▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.010▲ | 0.006▲ | 0.064▲ | 2.224▲ |
RSI | 49.200▼ | 46.059▼ | 44.302▼ | 41.277▼ | 24.212▼ |
STOCH | 50.000 | 69.260 | 61.227 | 14.670▼ | 6.441▼ |
WILL %R | -25.000▲ | -15.385▲ | -52.174 | -82.880▼ | -96.952▼ |
CCI | 38.377 | 58.131 | 7.267 | -118.929▼ | -74.935 |
▼ BREAK | $BHAT Price Breaks 10 Days Low | Set Alert |
Tuesday, April 29, 2025 05:00 AM
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.99 | 2.06 | 1.96 | 2.03 | 46,296 |
30/04/25 | 2.06 | 2.1199 | 1.8916 | 1.99 | 79,059 |
29/04/25 | 2.16 | 2.16 | 2.06 | 2.06 | 40,596 |
28/04/25 | 2.16 | 2.21 | 2.04 | 2.13 | 73,148 |
25/04/25 | 2.12 | 2.28 | 2.11 | 2.16 | 84,250 |
24/04/25 | 2.23 | 2.28 | 2.07 | 2.18 | 119,877 |
23/04/25 | 2.26 | 2.38 | 2.22 | 2.25 | 85,989 |
22/04/25 | 2.49 | 2.526 | 2.21 | 2.26 | 117,440 |
21/04/25 | 2.30 | 2.70 | 2.2701 | 2.47 | 267,537 |
17/04/25 | 2.15 | 2.40 | 2.15 | 2.37 | 119,291 |
|
|
||||
|
|
||||
|
|